emetine has been researched along with artesunate in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (93.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chibale, K; D'hooghe, M; de Kock, C; Desmet, T; Smith, PJ; Tran, HG; Vandekerckhove, S | 1 |
| Cloete, TT; de Kock, C; N'Da, DD; Smith, PJ | 1 |
| Birkholtz, LM; N'Da, DD; Smit, FJ; van Biljon, RA | 1 |
| Chibale, K; D'hooghe, M; Danneels, B; de Kock, C; Desmet, T; Smith, PJ; Van Herreweghe, S; Vandekerckhove, S; Willems, J | 1 |
| Beteck, RM; Birkholtz, LM; Coertzen, D; Haynes, RK; N'Da, DD; Smit, FJ | 1 |
| Combrinck, J; de Kock, C; N'Da, DD; Smit, FJ; Smith, PJ; Zuma, NH | 1 |
| Chibale, K; De Kock, C; Espinoza-Moraga, M; Kaur, G; Njoroge, M; Okombo, J; Singh, K; Smith, PJ; Wittlin, S | 1 |
| Chibale, K; Egan, TJ; Hunter, R; Joshi, MC; Ndove, J; Nsumiwa, S; Okombo, J; Taylor, D; Wiesner, L | 1 |
| Chibale, K; Chopra, R; Singh, K | 1 |
| Chibale, K; Kaur, G; Pavadai, E; Wittlin, S | 1 |
| Cheuka, PM; Chibale, K; Lawrence, N; Taylor, D; Wittlin, S | 1 |
| Attram, HD; Chibale, K; Wittlin, S | 1 |
| Baartzes, N; Chibale, K; Seldon, R; Smith, GS; Stringer, T; Taylor, D; Warner, DF; Wittlin, S | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
16 other study(ies) available for emetine and artesunate
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis of halogenated 4-quinolones and evaluation of their antiplasmodial activity.
Topics: 4-Quinolones; Animals; Antimalarials; Cell Survival; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2014 |
Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinin-triazine hybrids and hybrid-dimers.
Topics: Antimalarials; Artemisinins; Dimerization; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Plasmodium falciparum; Spectrophotometry, Infrared; Triazines | 2014 |
Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters.
Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Proliferation; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; Humans; MCF-7 Cells; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
Synthesis of functionalized 3-, 5-, 6- and 8-aminoquinolines via intermediate (3-pyrrolin-1-yl)- and (2-oxopyrrolidin-1-yl)quinolines and evaluation of their antiplasmodial and antifungal activity.
Topics: Aminoquinolines; Antifungal Agents; Antimalarials; Aspergillus flavus; Dose-Response Relationship, Drug; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodotorula; Structure-Activity Relationship | 2015 |
Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Decoquinate; Drug Resistance, Multiple; Emetine; Humans; Inhibitory Concentration 50; Plasmodium falciparum; Quinolones | 2016 |
Synthesis and biological evaluation of a series of non-hemiacetal ester derivatives of artemisinin.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Chemistry Techniques, Synthetic; CHO Cells; Cricetinae; Cricetulus; Drug Design; Esters; Humans; Plasmodium falciparum | 2016 |
Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agents.
Topics: Amides; Antimalarials; Chloroquine; Drug Resistance; Esters; Fusidic Acid; Plasmodium falciparum; Structure-Activity Relationship | 2017 |
4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Topics: Administration, Oral; Aminopyridines; Aminoquinolines; Animals; Antimalarials; Cell Membrane Permeability; Chloroquine; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; ERG1 Potassium Channel; Hemeproteins; Humans; Malaria; Male; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Solubility; Structure-Activity Relationship | 2017 |
Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity.
Topics: Animals; Antiprotozoal Agents; Binding Sites; Chlorocebus aethiops; Chloroquine; DNA; Drug Resistance; Hemin; Plasmodium falciparum; Pyrimidines; Vero Cells | 2018 |
Identification of steroid-like natural products as antiplasmodial agents by 2D and 3D similarity-based virtual screening.
Topics: | 2017 |
Antiplasmodial imidazopyridazines: structure-activity relationship studies lead to the identification of analogues with improved solubility and hERG profiles.
Topics: | 2018 |
Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles.
Topics: | 2019 |
Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrous Compounds; Malaria; Mice; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |